Summary of Significant Accounting Policies - Additional Information (Detail)		1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 16, 2025 USD ($)	Jul. 31, 2023 USD ($) shares	Jun. 30, 2025 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2025 USD ($) Segment	Jun. 30, 2024 USD ($)	Dec. 31, 2024 USD ($)
Number of operating segments | Segment					1
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]					srt:ChiefExecutiveOfficerMember
Cash in excess of federally insured limits			$ 1,011,747		$ 1,011,747
Cash equivalents			25,538		25,538		$ 25,374
Accounts receivable reserves			23,587		23,587		0
Reserve for inventory obsolescense			0		0		0
Gross patent costs			70,746		70,746		70,746
Accumulated Amortization			53,379		53,379		51,105
Asset impairment					0	$ 0
Amortization expense			$ 1,137	$ 1,132	$ 2,274	2,264
Revenue, performance obligation, description of timing					The Company has elected to apply the significant financing practical expedient, as allowed under ASC 606. As a result, the Company does not adjust the promised amount of consideration in a customer contract for the effects of a significant financing component when the period of time between when the Company transfers a promised good or service to a customer and when the customer pays for the good or service will be one year or less.
Revenue, performance obligation, description of payment terms					The Company has standard payment terms that generally require payment within approximately 30 days.
Finite-lived intangible assets, amortization period			16 years		16 years
Sales and marketing expenses			$ 345,505	11,045	$ 626,054	11,045
Unrecognized tax benefits			0		0		0
Accrued for interest and penalties			0		0		0
Net sales			503,612	12,320	1,013,965	12,320
Elevai Acquisition [Member]
Cash to be paid for acquisition	$ 56,525
One-time payment on closing date	500,000
Net sales	$ 500,000		503,612	$ 12,320	1,013,965	$ 12,320	2,500,000
True Health Inc. [Member]
Deferred offering costs			$ 65,000		$ 65,000
Equipment [Member] | Minimum [Member]
Property and equipment estimated useful lives			5 years		5 years
Equipment [Member] | Maximum [Member]
Property and equipment estimated useful lives			7 years		7 years
Leasehold Improvements [Member]
Property and equipment estimated useful lives			10 years		10 years
Furniture and Fixtures [Member]
Property and equipment estimated useful lives			7 years		7 years
2025 Private Placement [Member]
Deferred offering costs							$ 86,314
Meteora [Member] | Common Class A [Member] | Forward Purchase Agreement [Member]
Stock issued during period, shares, new issues | shares		56,865
Daily VWAP price		22.5